What are the symptoms of nasopharyngeal cancer in women

If the tumor occurs in the early stages of the pharyngeal recess, there may be tinnitus and a feeling of ear blockage, leading to secretory otitis media. In the later stages, bone damage invades the nerves and causes cranial nerve symptoms. At the same time, NPC patients often have cervical lymph node metastasis, which often appears deep in the neck. Female nasal cancer is common in nasal cavity cancer or paranasal sinus cancer. The epidemiology of NPC is characterized by obvious regional clustering, susceptibility of races and some populations, family clustering, and relatively stable incidence.

What is stage III nasopharyngeal cancer?

The third stage of NPC is middle and late stage NPC. Unlike cancers in other parts of the body, NPC generally does not require surgical treatment, except for patients with recurrent cancer. NPC is a common malignant tumor of the head and neck. Compared with the third stage, NPC may have a greater depth of invasion and may metastasize to the cervical lymph nodes. The diagnosis of this stage of NPC is mainly through pathological examination by nasopharyngeal endoscopy, and then further adjuvant radiotherapy and adjuvant chemotherapy are needed to control the development of the disease.

What should I do if the lesions of nasopharyngeal carcinoma are not significantly reduced after radiotherapy?

According to what you said, the tumor has not decreased, which indicates that the effect of radiotherapy is not ideal. The best way for patients with mid-stage nasopharyngeal carcinoma is symptomatic treatment. At present, Hualiu Decoction is the most suitable for treatment. Using TCM syndrome differentiation treatment, it can effectively alleviate the patient's symptoms, kill cancer cells, and reduce the disappearance of the tumor. After treatment of nasopharyngeal carcinoma, the tumor will decrease. About one month after radiotherapy, the efficacy evaluation can be carried out to evaluate the changes in the tumor. It is normal for the tumor to decrease but not disappear after radiotherapy for nasopharyngeal carcinoma.